Evolution Petroleum (EPM) reported a fiscal Q3 adjusted loss late Tuesday of $0.09 per diluted share, swinging from earnings of $0.02 a year earlier.
Analysts polled by FactSet expected earnings of $0.02.
Revenue in the three months ended March 31 fell to $20.2 million from $22.6 million a year earlier.
Analysts surveyed by FactSet expected $21.3 million.
Evolution shares fell 7.3% in after-hours trading.
Gyre Therapeutics Inc (GYRE) said China's regulator accepted its new drug application for F351, a treatment for chronic hepatitis B-induced liver fibrosis.The application, which received priority review status in March, marks "a significant milestone" in the program's path toward commercialization, the company said Tuesday in a statement.In the US, Gyre has completed a Phase 1 trial evaluating the drug's safety and tolerability in healthy volunteers and plans to file an investigational new drug application by the end of 2026, with a Phase 2 trial to follow if cleared.Gyre shares rose 1.4% in after-hours trading.
Arteris (AIP) reported a Q1 adjusted loss late Tuesday of $0.03 per diluted share, narrowing from the loss of $0.09 a year earlier.Four analysts polled by FactSet expected a loss of $0.07.Revenue in the three months ended March 31 rose to $22.9 million from $16.5 million a year earlier.Four analysts surveyed by FactSet expected $21 million.The company expects revenue of $23 million to $24 million in Q2 and $91 million to $95 million in the full year. Four analysts expect $22 million in Q2 and $91 million in the full year.Arteris shares rose 7.9% in after-hours trading.The company also said Chief Financial Officer Nicholas Hawkins plans to retire effective Aug. 31, and the board has started a search for a new CFO.
Nextpower (NXT) reported fiscal Q4 adjusted earnings late Tuesday of $1.05 per diluted share, down from $1.29 a year earlier.Analysts polled by FactSet expected $0.92.Revenue in the three months ended March 31 fell to $880.5 million from $924.3 million a year earlier.Analysts surveyed by FactSet expected $826.3 million.Nextpower expects fiscal 2027 adjusted EPS of $4.21 to $4.59. Analysts expect $4.72.The company boosted full-year revenue guidance to $3.8 billion to $4.1 billion from the prior forecast of $3.6 billion to $3.8 billion earlier. Analysts expect $3.92 billion.The company said separately it will acquire complementary assets of Zigor's power conversion business and its US unit Apex Power for $80.5 million. That includes $46 million at closing and up to $34.5 million in potential earnouts.Nextpower shares rose 11% in after-hours trading.